OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA北美妇产科临床
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA(英文缩写 OBSTET GYN CLIN N AM),ISSN 0889-8545,eISSN 1558-0474,中文译名:北美妇产科临床 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-28 至 2026-09-28，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 2.838 | Q3 |
| 2022 | 3.200 | Q2 |
| 2023 | 2.600 | Q2 |
| 2024 | 2.500 | Q2 |
| 2025 | 1.900 | Q3 |
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA 最新收录文献
-
3. Optimizing Menopause Care for Diverse Populations.
3. 优化不同人群的更年期护理PMID:日期:2026-09-01Equitable menopause care demands systemic, clinical, and research reforms. Guided by the National Institute on Minority Health and Health Disparities framework and an intersectional lens, we emphasize how sociocultural factors, the physical/built environment, behaviors, biology, and health care systems jointly heighten menopause symptom burden-especially for marginalized groups. Priorities include addressing health literacy; developing multilingual, culturally responsive educational tools; integrating menopause curricula, bias training, and trauma-informed strategies-into clinical education; and expanding insurance coverage. Inclusive recruitment and retention strategies in menopause research, plus coordinated, interdisciplinary care, are essential to deliver personalized, culturally responsive interventions and improve midlife women's outcomes.
-
4. Menopausal Considerations in Transgender and Gender-Diverse Individuals.
PMID:日期:2026-09-01Assessing and treating menopause in transgender and gender diverse (TGD) individuals is of increasing interest to clinicians providing gender-affirming care. There currently exists a small body of literature that describes cardiovascular, bone health, neurocognitive, and other outcomes in the TGD population who experience loss of endogenous sex hormone production, whether through gender-affirming hormone therapy, surgical gonadectomy, or natural aging. However, the literature is currently insufficient to provide clear evidence-based guidance for the medical management of menopause in TGD individuals. As a result, clinical care largely relies on extrapolation from cisgender populations, expert opinion, clinical consensus, and shared decision-making.
-
5. Menopause in Cancer Survivors.
PMID:日期:2026-09-01Millions of women worldwide are diagnosed with cancer annually. Although most of these cancers do not directly impact reproductive organs, the cancer therapies used treat these tumors, namely surgery, radiation, chemotherapy, immunotherapies and hormonal agents, can drastically alter women's lives forever. The direct effects of cancer treatment on reproductive organs may alter fertility and induce temporary or permanent menopause. The psychological and physiologic impact of menopause on survivors is enormous. The loss of estrogen impacts cardiovascular, musculoskeletal, and neurologic health, quality of life, and long-term well-being.
-
6. The Menopausal Transition and Cardiovascular Aging: Implications for Prevention in Midlife.
PMID:日期:2026-09-01Midlife is a critical period for cardiovascular health, especially for women undergoing the menopause transition. During this time, normal cardiovascular aging may accelerate in the presence of unhealthy lifestyle behaviors and cardiometabolic risk factors such as hypertension, dyslipidemia, insulin resistance, obesity, chronic inflammation, and environmental exposures. The dynamic interaction between vascular and myocardial structural and functional remodeling, alongside cellular hallmarks of cardiovascular aging, underscores the biological complexity of this period. Importantly, lifestyle behaviors and cardiovascular health scores can serve as modifiable targets, highlighting a critical opportunity for early preventive strategies to support healthy aging.
-
7. Bone Health and Osteoporosis Prevention in Menopause.
7. 绝经期骨骼健康与骨质疏松症预防PMID:日期:2026-09-01Osteoporosis is a systemic skeletal disorder characterized by reduced bone strength and increased fracture risk, posing a major public health challenge. Hip and vertebral fractures, which predominantly affect older postmenopausal women, lead to significant disability and reduced quality of life. Accelerated bone loss begins during the menopausal transition, and early fractures (eg, wrist) can signal underlying skeletal fragility. Although effective screening tools and evidence-based lifestyle and pharmacologic interventions can prevent fractures, osteoporosis remains underdiagnosed and undertreated. Women's health clinicians play a critical role in integrating bone health assessment, prevention, and management into routine care for perimenopausal and postmenopausal women.
-
8. Weight Management in Menopause: Diet, Physical Activity, Medication, and Surgery.
PMID:日期:2026-09-01During the menopausal transition and into early menopause, women gain body fat, particularly centrally, and lose lean mass. There is a worsening of cardiometabolic risk factors including insulin resistance, dyslipidemia, and vascular function. Combined diet and exercise interventions, particularly when employed during the menopausal transition, show evidence for improvement in weight, body composition, and metabolic risk factors. Although there are limited data on the effects of first-generation and second-generation antiobesity medications and bariatric surgery, glucagon-like peptide 1 receptor agonists are promising agents to prevent and mitigate adverse changes in body composition and cardiometabolic risk.
-
9. Midlife Sleep and Circadian Health: Implications for Cardiovascular and Cognitive Outcomes.
PMID:日期:2026-09-01Midlife women, particularly during the menopausal transition, experience heightened vulnerability to sleep and circadian health disturbances. These disruptions are driven by hormonal changes, vasomotor symptoms, psychosocial stress, and aging-related factors. Poor sleep and circadian health are linked to an increased risk for cardiovascular disease, metabolic dysfunction, and cognitive performance decrements. Evidence-based interventions include hormone therapy, selective pharmacologic treatments, and nonpharmacologic approaches such as cognitive-behavioral therapy for insomnia, exercise, and mindfulness. Targeting both sleep and circadian domains may improve midlife women's health trajectories and support healthy aging.
-
10. Midlife Vulvovaginal and Sexual Health.
PMID:日期:2026-09-01The menopause transition and post-menopause are associated with genitourinary changes that can impact sexual function and overall quality of life. Declining estrogen levels due to cessation of ovarian follicular function triggers these changes and may also contribute to or exacerbate other vulvar conditions. Prompt recognition of the spectrum of normal menopausal vulvovaginal changes, distinguishing them from pathologic conditions, and understanding the multifactorial influences on vulvovaginal health is integral to care of women in midlife and beyond.